Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dipylon puts $3.8m into heart monitor launch

This article was originally published in Clinica

Executive Summary

Swedish heart monitoring device company Dipylon Medical has secured SKr27.5m ($3.8m) in a series A financing round. The capital, which was provided by Dipylon's manufacturing and technology licensing partner CMA Microdialysis, will go towards the initial launch of the Dipylon cardiac catheter. The product was CE marked in January, and is designed to provide continuous metabolic measurements of the heart muscle inside the coronary sinus. The new capital will also be used to support more extensive international studies of the technology. Prior to this round, Solna-based Dipylon had received SKr0.5m in seed funding from business angel group Escritura.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041600

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel